1David S. Kotlyar,Mark T. Osterman,Robert H. Diamond,David Porter,Wojciech C. Blonski,Mariusz Wasik,Sami Sampat,Manuel Mendizabal,Ming V. Lin,Gary R. Lichtenstein.A Systematic Review of Factors That Contribute to Hepatosplenic T-Cell Lymphoma in Patients With Inflammatory Bowel Disease[J]. Clinical Gastroenterology and Hepatology . 2011 (1)
2Christian Münz,Ann Moormann.Immune escape by Epstein–Barr virus associated malignancies[J]. Seminars in Cancer Biology . 2008 (6)
3Natalie A. Molodecky,Ing Shian Soon,Doreen M. Rabi,William A. Ghali,Mollie Ferris,Greg Chernoff,Eric I. Benchimol,Remo Panaccione,Subrata Ghosh,Herman W. Barkema,Gilaad G. Kaplan.Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review[J].Gastroenterology.2012(1)
4Laurent Peyrin–Biroulet,Kiarash Khosrotehrani,Fabrice Carrat,Anne–Marie Bouvier,Jean–Baptiste Chevaux,Tabassome Simon,Frank Carbonnel,Jean–Frédéric Colombel,Jean–Louis Dupas,Philippe Godeberge,Jean–Pierre Hugot,Marc Lémann,Stéphane Nahon,Jean–Marc Sabaté,Gilbert Tucat,Laurent Beaugerie.Increased Risk for Nonmelanoma Skin Cancers in Patients Who Receive Thiopurines for Inflammatory Bowel Disease[J].Gastroenterology.2011(5)
5W. G.Dixon,K. D.Watson,M.Lunt,L. K.Mercer,K. L.Hyrich,D. P. M.Symmons.Influence of anti–tumor necrosis factor therapy on cancer incidence in patients with rheumatoid arthritis who have had a prior malignancy: Results from the British Society for rheumatology biologics register[J].Arthritis Care Res.2010(6)
6Nika N Danial,Stanley J Korsmeyer.Cell Death[J].Cell.2004(2)
7Millie D. Long,Christopher F. Martin,Clare A. Pipkin,Hans H. Herfarth,Robert S. Sandler,Michael D. Kappelman.Risk of Melanoma and Nonmelanoma Skin Cancer Among Patients With Inflammatory Bowel Disease[J]. Gastroenterology . 2012 (2)
8Millie D. Long,Hans H. Herfarth,Clare A. Pipkin,Carol Q. Porter,Robert S. Sandler,Michael D. Kappelman.Increased Risk for Non-Melanoma Skin Cancer in Patients With Inflammatory Bowel Disease[J]. Clinical Gastroenterology and Hepatology . 2010 (3)
9Harrison Michelle L,Obermueller Eva,Maisey Nick R,Hoare Susan,Edmonds Kim,Li Ningfeng F,Chao David,Hall Kate,Lee Chooi,Timotheadou Eleni,Charles Kellie,Ahern Roger,King D Mike,Eisen Tim,Corringham Robert,DeWitte Mark,Balkwill Frances,Gore.Tumor necrosis factor alpha as a new target for renal cell carcinoma: two sequential phase II trials of infliximab at standard and high dose. Journal of clinical oncology : official journal of the American Society of Clinical Oncology . 2007
10Vogelstein B,Papadopoulos N,Velculescu V E,Zhou S,Diaz L A Jr,Kinzler K W.Cancer genome landscapes. Science . 2013
